AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 788990 — intervention group
Group type: COMPARATOR
Intervention: Racemic methadone
Number of subjects: 66
Study 31425384 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised isometric exercise (n = 21)
Number of subjects: 40
Study 31425384 — intervention group
Group type: COMPARATOR
Intervention: Wait-and-see (n = 19)
Number of subjects: 40
Study 31042696 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (0.75 or 1.5 mg/kg)
Number of subjects: 36
Study 31042696 — intervention group
Group type: COMPARATOR
Intervention: MA (20 mg)
Number of subjects: 36
Study 31042696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 28550194 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive diabetes therapy (mean HbA1c of ∼7%)
Number of subjects: 0
Study 28550194 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes therapy (mean HbA1c of 9%)
Number of subjects: 0
Study 25545240 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 165
Study 25545240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 23392369 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam/ketamine prior to lumbar puncture (Group A)
Number of subjects: 25
Study 23392369 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine only prior to lumbar puncture (Group B)
Number of subjects: 25
Study 23392369 — intervention group
Group type: COMPARATOR
Intervention: Non-ketamine-sedated patients (Group C)
Number of subjects: 25
Study 21069306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tracing
Number of subjects: 16
Study 21069306 — intervention group
Group type: COMPARATOR
Intervention: Copying
Number of subjects: 16
Study 20368377 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayurvedic zinc tablet (jasad bhasma)
Number of subjects: 180
Study 20368377 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc-rich snacks
Number of subjects: 180
Study 20368377 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study 18040619 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion of an 8-mm Penrose drain retained below the liver bed for 42 hours (Group A)
Number of subjects: 120
Study 18040619 — intervention group
Group type: COMPARATOR
Intervention: No drain retained (Group B)
Number of subjects: 120
Study 18040619 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertion of an 8-mm Penrose drain (Group A)
Number of subjects: 120
Study 15110726 — intervention group
Group type: EXPERIMENTAL
Intervention: Caucasian participants recognizing own-race faces
Number of subjects: 0
Study 15110726 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian participants recognizing own-race and other-race faces
Number of subjects: 0
Study 11679507 — intervention group
Group type: EXPERIMENTAL
Intervention: Conscious sedation/local anaesthesia (group A)
Number of subjects: 67
Study 11679507 — intervention group
Group type: COMPARATOR
Intervention: General anaesthesia (group B)
Number of subjects: 67
Study 9692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride (sodium fluoride 50 mg/day or monofluorophosphate 200 mg/day or 150 mg/day)
Number of subjects: 354
Study 9692071 — intervention group
Group type: COMPARATOR
Intervention: Calcium-vitamin D (1 g of calcium and 800 IU of vitamin D2 daily)
Number of subjects: 354
Study 9692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride
Number of subjects: 354
Study 9692071 — intervention group
Group type: COMPARATOR
Intervention: Calcium-vitamin D
Number of subjects: 354
Study 9692071 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride after cessation
Number of subjects: 354
Study 8820898 — intervention group
Group type: EXPERIMENTAL
Intervention: Downhill running at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10
Study 8820898 — intervention group
Group type: COMPARATOR
Intervention: Level running at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10
Study 8820898 — intervention group
Group type: EXPERIMENTAL
Intervention: Uphill running at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10
Study 8820898 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill speed at 4.0 mmol.l‐1 [La‐]b
Number of subjects: 10
Study 8820898 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of RPE with HR at both [La‐]b
Number of subjects: 10
Study 8820898 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of treadmill speed with RPE at 2.0 mmol.l‐1 [La‐]b
Number of subjects: 10
Study 2389831 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg/twice daily for 21 days)
Number of subjects: 15
Study 2389831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 6273020 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisone acetate (25 mg)
Number of subjects: 12
Study 6273020 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (20 mg)
Number of subjects: 12
Study 6273020 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid withdrawal
Number of subjects: 12
Study 31852441 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-structured briefing (SG)
Number of subjects: 37
Study 31852441 — intervention group
Group type: COMPARATOR
Intervention: Usual routine (CG)
Number of subjects: 37
Study 27810253 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided arthrocentesis
Number of subjects: 18
Study 27810253 — intervention group
Group type: COMPARATOR
Intervention: Landmark-guided arthrocentesis
Number of subjects: 18
Study 25970751 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 g bilberries daily for 7 days
Number of subjects: 0
Study 25970751 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 g bilberries daily for 7 days
Number of subjects: 0
Study 25970751 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inactive product - starch)
Number of subjects: 0
Study 25970751 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (debridement only)
Number of subjects: 0
Study 25188752 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCESS treatment model (integrated care including therapeutic assertive community treatment)
Number of subjects: 115
Study 23159954 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency rTMS (1 Hz)
Number of subjects: 15
Study 23159954 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency rTMS (10 Hz)
Number of subjects: 15
Study 23159954 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 15
Study 20145487 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Relaxation (FR)
Number of subjects: 64
Study 20145487 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Imagery (GI)
Number of subjects: 64
Study 20145487 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Relaxation and Guided Imagery (FR/GI)
Number of subjects: 64
Study 20145487 — intervention group
Group type: COMPARATOR
Intervention: Control Intervention (CI)
Number of subjects: 64
Study 18576295 — intervention group
Group type: EXPERIMENTAL
Intervention: Chicken type II collagen (CCII) 0.1 mg/day
Number of subjects: 236
Study 18576295 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) 10 mg/week
Number of subjects: 236
Study 15811207 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 2.5 mg ODT
Number of subjects: 608
Study 15811207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 608
Study 12219994 — intervention group
Group type: EXPERIMENTAL
Intervention: Emedastine 0.05% eye drops
Number of subjects: 30
Study 12219994 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil 2% eye drops
Number of subjects: 30
Study 12219994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 10619342 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge with different fish species
Number of subjects: 9
Study 10619342 — intervention group
Group type: COMPARATOR
Intervention: Skin prick test
Number of subjects: 9
Study 10619342 — intervention group
Group type: COMPARATOR
Intervention: RAST
Number of subjects: 9
Study 8826270 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating-pressure supports
Number of subjects: 43
Study 8826270 — intervention group
Group type: COMPARATOR
Intervention: Constant-low-pressure supports
Number of subjects: 43
Study 1481761 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous pharyngostomy
Number of subjects: 50
Study 1481761 — intervention group
Group type: COMPARATOR
Intervention: Conventional nasal placement of nasogastric tubes
Number of subjects: 50
Study 6377070 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 269
Study 6377070 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 31181536 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic sentinel lymph node (SLN) algorithm using indocyanine green (ICG)
Number of subjects: 257
Study 31181536 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall SLN algorithm (including macroscopically suspect nodes as SLNs)
Number of subjects: 257
Study 31181536 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral mapping rate
Number of subjects: 257
Study 31181536 — intervention group
Group type: EXPERIMENTAL
Intervention: SLN procedure
Number of subjects: 257
Study 29204652 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Continuous Positive Airway Pressure (NCPAP)
Number of subjects: 135
Study 29204652 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 135
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2-mL bolus injection over 5 s
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-mL injection over 1 min
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-mL injection over 4 min
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-mL injection over 10 min
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: All injections
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5-mL injections
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2-mL injections
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-min injections
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-min injections
Number of subjects: 48
Study 25693652 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-min injections
Number of subjects: 48
Study 23928715 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocker sole shoes
Number of subjects: 115
Study 23928715 — intervention group
Group type: COMPARATOR
Intervention: Flat sole shoes
Number of subjects: 115
Study 23928715 — intervention group
Group type: COMPARATOR
Intervention: Flat sole shoes (for those reporting pain when standing and walking)
Number of subjects: 115
Study 23928715 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocker sole shoes (for those reporting pain when standing and walking)
Number of subjects: 115
Study 21718484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginseng capsule (100 mg) twice daily for 24 weeks
Number of subjects: 168
Study 21718484 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo twice daily for 24 weeks
Number of subjects: 168
Study 18829631 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical prednisolone phosphate
Number of subjects: 42
Study 18829631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 17712235 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (n = 55)
Number of subjects: 176
Study 17712235 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 58)
Number of subjects: 176
Study 15080599 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB, arginine, and glutamine supplementation
Number of subjects: 109
Study 15080599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 11576977 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialist nurse intervention
Number of subjects: 165
Study 11576977 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 165
Study 8418403 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleus multichannel implant (implant 2)
Number of subjects: 82
Study 8418403 — intervention group
Group type: EXPERIMENTAL
Intervention: Ineraid multichannel implant (implant 1)
Number of subjects: 82
Study 8418403 — intervention group
Group type: COMPARATOR
Intervention: 3M/Vienna single‐channel implant (implant 3)
Number of subjects: 82
Study 8418403 — intervention group
Group type: EXPERIMENTAL
Intervention: Nucleus multichannel implant (implant 2) with improved speech processor
Number of subjects: 82
Study 3769719 — intervention group
Group type: EXPERIMENTAL
Intervention: Group management program
Number of subjects: 32
Study 3769719 — intervention group
Group type: COMPARATOR
Intervention: Advice-educational technique
Number of subjects: 32
Study 3769719 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (both interventions)
Number of subjects: 32
Study 29779044 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterolateral internal sphincterotomy (PLIS)
Number of subjects: 80
Study 29779044 — intervention group
Group type: COMPARATOR
Intervention: Lateral internal sphincterotomy (LIS)
Number of subjects: 80
Study 29779044 — intervention group
Group type: EXPERIMENTAL
Intervention: PLIS
Number of subjects: 80
Study 29779044 — intervention group
Group type: COMPARATOR
Intervention: LIS
Number of subjects: 80
Study 27031685 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepilex® dressing
Number of subjects: 10
Study 27031685 — intervention group
Group type: EXPERIMENTAL
Intervention: Allevyn dressing
Number of subjects: 10
Study 27031685 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquacel™ dressing
Number of subjects: 10
Study 27031685 — intervention group
Group type: COMPARATOR
Intervention: Control (no dressing)
Number of subjects: 10
Study 24859589 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal fusion (surgery)
Number of subjects: 464
Study 24859589 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 464
Study 23727415 — intervention group
Group type: EXPERIMENTAL
Intervention: mirabegron 50 mg
Number of subjects: 200
Study 23727415 — intervention group
Group type: EXPERIMENTAL
Intervention: mirabegron 100 mg
Number of subjects: 200
Study 23727415 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 200
Study 19716267 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrandomized comparative studies (NRCSs) of laparoscopic resection for colorectal cancer
Number of subjects: 8950
Study 19716267 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trials (RCTs) of laparoscopic resection for colorectal cancer
Number of subjects: 8950
Study 17938146 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother-infant or toddler parenting program (n = 65)
Number of subjects: 118
Study 17938146 — intervention group
Group type: COMPARATOR
Intervention: Enhanced waitlist group (n = 53)
Number of subjects: 118
Study 16984640 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascial interposition (FI) during vas occlusion by ligation and excision
Number of subjects: 1215
Study 16984640 — intervention group
Group type: EXPERIMENTAL
Intervention: Ligation and excision without FI
Number of subjects: 1215
Study 16984640 — intervention group
Group type: COMPARATOR
Intervention: Thermal cautery without FI
Number of subjects: 1215
Study 16984640 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1215
Study 14504948 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise-trained subjects
Number of subjects: 0
Study 14504948 — intervention group
Group type: COMPARATOR
Intervention: Untrained subjects
Number of subjects: 0
Study 14504948 — intervention group
Group type: EXPERIMENTAL
Intervention: Sinusoidal exercise
Number of subjects: 0
Study 14504948 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise-trained and untrained subjects
Number of subjects: 0
Study 10731455 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair-climbing group (N = 12)
Number of subjects: 22
Study 10731455 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 10)
Number of subjects: 22
Study 8958000 — intervention group
Group type: COMPARATOR
Intervention: Conventional formula lacking LCP (n=16)
Number of subjects: 43
Study 8958000 — intervention group
Group type: EXPERIMENTAL
Intervention: 22:6n-3- and 20:4n-6-enriched formula (n=15)
Number of subjects: 43
Study 8958000 — intervention group
Group type: COMPARATOR
Intervention: Mother's breast milk (n=12)
Number of subjects: 43
Study 1432827 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast stimulation
Number of subjects: 60
Study 1432827 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion
Number of subjects: 60
Study 1432827 — intervention group
Group type: COMPARATOR
Intervention: No method employed (Control)
Number of subjects: 60
Study 2872950 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 40
Study 2872950 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 40
Study 2872950 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancuronium-metocurine mixture
Number of subjects: 40
Study 2872950 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 40
Study 31526207 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.25, 0.5, 1 mg/kg) administered at weekly intervals
Number of subjects: 12
Study 31526207 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.01 mg/kg)
Number of subjects: 12
Study 29352421 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 3913
Study 29352421 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education
Number of subjects: 3913
Study 29352421 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 3913
Study 27831984 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Patient-Reported Outcomes (PROs) including ODI, Scoliosis Research Society-23, Short Form-12
Number of subjects: 286
Study 27831984 — intervention group
Group type: EXPERIMENTAL
Intervention: Subset analysis of high-symptom patients (ODI ≥ 40)
Number of subjects: 286
Study 25337988 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention for health care professionals
Number of subjects: 69
Study 23411526 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser preparation
Number of subjects: 53
Study 23411526 — intervention group
Group type: COMPARATOR
Intervention: Mechanical preparation
Number of subjects: 53
Study 20890176 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (100 mg of alteplase: 10 mg bolus followed by 90 mg intravenous infusion over 2 hours)
Number of subjects: 72
Study 20890176 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo)
Number of subjects: 72
Study 20890176 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (100 mg of alteplase)
Number of subjects: 72
Study 19458433 — intervention group
Group type: EXPERIMENTAL
Intervention: TBI participants
Number of subjects: 7
Study 19458433 — intervention group
Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 7
Study 16684811 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0
Study 16684811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15205959 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium and stainless steel blocks at surface temperatures of -2 degrees C and -10 degrees C, with contact forces of 1.0 N and 9.8 N.
Number of subjects: 14
Study 15205959 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow cooling conditions (>45 s to reach T(C)=1 degrees C) with index finger volume as a measure of hand size.
Number of subjects: 14
Study 15205959 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast cooling conditions (<25 s to reach T(C)=1 degrees C).
Number of subjects: 14
Study 11166484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural intervention (CBT)
Number of subjects: 53
Study 11166484 — intervention group
Group type: COMPARATOR
Intervention: Standard care (Control)
Number of subjects: 53
Study 9292807 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium YAG laser
Number of subjects: 70
Study 9292807 — intervention group
Group type: COMPARATOR
Intervention: Conventional cutting tools
Number of subjects: 70
Study 8161937 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-grade non-Hodgkin's lymphoma (LG-NHL)
Number of subjects: 496
Study 3536261 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg methylprednisolone
Number of subjects: 0
Study 3536261 — intervention group
Group type: COMPARATOR
Intervention: 250 mg methylprednisolone
Number of subjects: 0
Study 30146282 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 g/d of regular cheese for 2 weeks
Number of subjects: 17
Study 30146282 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet for 2 weeks
Number of subjects: 17
Study 27632557 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 10 mg
Number of subjects: 27
Study 27632557 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 20 mg
Number of subjects: 27
Study 27632557 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine 40 mg
Number of subjects: 27
Study 27632557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 27632557 — intervention group
Group type: EXPERIMENTAL
Intervention: Rupatadine (all doses)
Number of subjects: 27
Study 24920841 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab (RTX)
Number of subjects: 41
Study 22421169 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/day
Number of subjects: 1005
Study 22421169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1005
Study 20546674 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cells (BMMC) injected into the left ventricular free wall (9.6 ± 2.6 × 10(7) BMMC divided into 10 points)
Number of subjects: 15
Study 20546674 — intervention group
Group type: EXPERIMENTAL
Intervention: BMMC injection into the left ventricular free wall
Number of subjects: 15
Study 18937123 — intervention group
Group type: EXPERIMENTAL
Intervention: Male partner with experience of extradyadic sexual activity (ESA)
Number of subjects: 399